Assay Detects and Differentiates Trichomonas vaginalis and Mycoplasma genitalium in Urine
The NeuMoDx TV/MG assay implemented on the NeuMoDx Molecular system allows for automated detection of T. vaginalis and M. genitalium simultaneously.
Read MorePosted by | Apr 6, 2020 | Infectious Diseases, Molecular Diagnostics, Sexually Transmitted Diseases |
The NeuMoDx TV/MG assay implemented on the NeuMoDx Molecular system allows for automated detection of T. vaginalis and M. genitalium simultaneously.
Read MorePosted by | Apr 6, 2020 | Diagnostic Technologies |
The partnership will utilize ProSciento’s NASH Pass patient registry and Nordic Bioscience’s biomarker technology to identify and validate translational biomarkers to improve the diagnosis, prognosis, and development of therapeutics for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Read MorePosted by | Apr 2, 2020 | Blood Gas Analyzers, Clinical Chemistry, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Already available in countries requiring the CE mark, the RapidPoint 500e blood gas analyzer is now available for critical care testing in the United States.
Read MorePosted by | Mar 31, 2020 | Cleaners & Disinfectants, Covid 19, Emerging & Zoonotic Diseases, Eyeware & Facial Protection, Eyewash & Showers, Infectious Diseases, Lab Safety, Labcoats, Gloves & Apparel, Power Surge Protectors |
FDA has acted to facilitate the importation of products—including personal protective equipment and medical devices needed to help fight the covid-19 pandemic—into the United States.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Abbott’s new test is the fastest available molecular point-of-care test for the diagnosis of covid-19, delivering positive results in as little as 5 minutes and negative results in 13 minutes.
Read More